Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I personally think this thing can be worth atleast 100 million if they execute, and personally think they will be bought out in the long run.
Also in no way am I saying its worth 1 billion, but the potential here is great. Even google or amazon can buy out to add that capability. Thing here is it needs to gain user base. It has a unique feature that no one currently is considering in terms of a navigation app. When I downloaded Waze in 2011 it was not well known. Apps do catch steam very quick. So this thing has a lot of upside from here the downside not as much.
This isnt any normal app. It will contain big data & analytics. Its a lot different from the normal apps people use day to day. IT currently already has data and technology built into it. I am sure they plan to expand that technology and bring much more insight than currently provided. Assuming they can execute!
Once an app gains traction and user base its a whole different ball game. Either way not one to be shorted.
This merger is very huge actually. This can bring some seriously large evaluation down the road and the potential to be bought out. Currently RedZOne maps is only available via itunes, if they expand to google play store they will have a large additional market to entire.
Look here at the price tag of Waze, bought for over 1 billion by google. Interestingly here RedZone provides a very unique capability via navigation.
http://www.bizjournals.com/sanjose/news/2014/04/07/waze-cost-1-15-cofounder-hints-investors-forced.html
The move to $4.5 was super quick.
This is old news but interesting from the link in the last comment "Pierre Fabre has been granted the option to license any, or all, of the new drug conjugates developed as part of the research collaboration, while Cellectar will own all intellectual property (IP) associated with the new drug conjugates."
Why the big volume and pop in share price last couple of days and weeks in general?
How do you see those big lot buys? Nasdaq.com?
Mr-Meeseeks, your short the stock?
PRGN what do you think of this one going forward? Any upside here? Or delisted from nasdaq.com?
Woops my bad. Not 50% of float but 400K
http://www.nasdaq.com/symbol/clrb/short-interest
This 40568 shorted shares are as of May 13th, 2016. Its prob 10 times that now. This is looking like a great runner and plenty left. The next short interest update from nasdaq's website will be releast on June 9th for May 31st.
I bet this stock is short 50% of float! This will touch $10
Time to load the truck now! Buy!
Definitely some interesting volume on CLRB. Earlier in the morning there was an article on shorts which created that late pre-market pop. But now I dont see it in google.com/finance. Will check history later. Did anyone else see it?
Wonder what the pop was all about considering it was apparently prior to the conference today.
The drop at 2:34pm EST was a little weird.
The conference is at 3:30pm eastern time? So this thing popped prior?
Earlier this morning I read an article about the short doubling but the numbers were small. and I cant find the article its on my other computer will try and post that later.
But I actually got out of this position around 3.20 and picked up some EBIO for a quick trade and then luckly got back in around 3.70. Phew~..
Agree with some of the others about a nice looking chart!
Is asuv over?
What do you guys think of a small position in ccxi?
Sorry I mean. Post as in now. I do believe they can hit 10 but just sooner the better would be nice.
I feel with the run down towards $1 and post patent, it should get somewhere in the 10's. But I dont really want to wait long. I will try to get in tomorrow and wait for a big move and re-eval then. Getting to 10 quick would require a huge short. I dont have those numbers.
What is the advantage of a pink sheets company that has a product that is FDA approved? Can this ever get on the Nasdaq?
Hey guys great group. I missed out on the ASUV discussion. What was the main reason for the run up over the last three months? Is it to late to jump in on a new position?
Btw whats up with the $700 dollar target on CLRB, that would value it in the Billions?
But the market cap is very low?
In pre-market it hit as high as 15. I suspect a large short position was made and likely there will be a lot of covering soon. This can touch 15 in the near term, and will prob be in a blink of an eye.
Thats great news. The market loved this news. I suspect a lot of people probably also shorted this and may create some sort of short squeeze. Hypothetically how far away are they from something commercial? Has the company mentioned the possibilities of a partnership?
What exactly about the trial data would make this stock shoot to an all time high in its complete history. The market cap was fairly as is? None the less great run!
CLRB:: Looks like there has been a lot of shorting of CLRB? Can anyone confirm?
NERV: What a pop today late with NERV. Wish I got in.
What do you guys think of CCXI?
But I am confused about the actual number of shares outstanding? is it 3.4Million? They had a split a while back as well.
The Company ended the first quarter with $1.9 million in cash and cash equivalents, compared to $3.9 million in cash and cash equivalents on December 31, 2015. When added to the approximately $7.2 million generated from the recently completed public offering, the company estimates that its available cash and cash equivalents should fund its planned operations into the first quarter of 2017. However, the company expects that additional capital will be required to complete its planned clinical and preclinical development.
http://news.money.ca/2016/05/12/cellectar-biosciences-announces-first-quarter-2016-financial-results/